FindTrial
Sign In

Comparison of effectiveness of two drugs Dexamethasone and Dexmedetomidine as additives in Supraclavicular Brachial Plexus Block

A comparison between low dose Dexamethasone (2 mg) and low dose Dexmedetomidine (50 mcg) as an adjuvant to 0.5% Ropivacaine in Supraclavicular Brachial Plexus Block- A Randomized Placebo Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025457
Enrollment
100
Registered
2020-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexamethasone: Low dose dexamethasone (2mg) given as adjuvant to 0.5% ropivacaine in supraclavicular brachial plexus block Intervention2: Dexmedetomidine: Low dose dexmedetomidine (50 m

Sponsors

MS Ramaiah Medical College and hospitals
Lead Sponsor
Dr Mahdiyyah Mariam
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)American Society of Anaesthesiologists (ASA) grade I-II 2)Posted for elective upper limb surgeries

Exclusion criteria

Exclusion criteria: 1)Known case of hypersensitivity reaction to local anaesthetics, dexamethasone or dexmedetomidine 2)Uncontrolled Diabetic or Hypertensive patients 3)Patients who are pregnant or breast feeding. 4)Coagulation abnormalities 5)Significant hepatic, renal or cardiopulmonary abnormalities 6)Local skin infections at the site of puncture for supraclavicular block

Design outcomes

Primary

MeasureTime frame
Duration of AnalgesiaTimepoint: The time at which the patient first complains of post-operative pain at the surgical site which is assessed every 4 hours in the post operative period—

Secondary

MeasureTime frame
Duration of motor blockadeTimepoint: Post operatively, when the patient regains motor function, assessed every 4 hours in the post operative period;Onset of sensory and motor blockade Adverse events like bradycardia, hypotension, sedation, nausea or vomiting and hypoxemiaTimepoint: Intraoperatively, every 5 minutes after giving the supraclavicular block.—

Countries

India

Contacts

Public ContactDr Leena H Parate

MS Ramaiah Medical College

dr_leenag@yahoo.co.in9480525925

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026